Patents by Inventor Hera Vlamakis

Hera Vlamakis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cholesterol reducing compositions and methods of use thereof
    Patent number: 12138285
    Abstract: Microbes expressing cholesterol oxidoreductase (COR) proteins, methods of engineering the microbes expressing COR proteins, compositions and methods of using the microbes are provided.
    Type: Grant
    Filed: March 6, 2023
    Date of Patent: November 12, 2024
    Inventors: Douglas Kenny, Hera Vlamakis, Ramnik Xavier, Emily Balskus, Damian Plichta
  • BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISMS, COMPOSITIONS AND USES THEREOF
    Publication number: 20240301345
    Abstract: Described in several exemplary embodiments are Bifidobacterium longum subspecies, microorganisms and formulations thereof. Described in several exemplary embodiments are formulations, such as synthetic formulations, that contain one or more of the Bifidobacterium longum subspecies microorganisms. Described in several embodiments herein is use of the Bifidobacterium longum subspecies microorganisms and formulations thereof, such as in an infant and/or young child.
    Type: Application
    Filed: June 28, 2022
    Publication date: September 12, 2024
    Inventors: Ramnik Xavier, Hera Vlamakis, Tommi Vatanen, Olga Sakwinska, Léa Siegwald, Stéphane Duboux, Catherine Ngom-Bru
  • CHOLESTEROL REDUCING COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20240024381
    Abstract: Microbes expressing cholesterol oxidoreductase (COR) proteins, methods of engineering the microbes expressing COR proteins, compositions and methods of using the microbes are provided.
    Type: Application
    Filed: March 6, 2023
    Publication date: January 25, 2024
    Inventors: Douglas Kenny, Hera Vlamakis, Ramnik Xavier, Emily Balskus, Damian Plichta
  • Methods of treating and diagnosing IBD associated with r. gnavus and/or r. gnavus group IBD colonization
    Patent number: 11806372
    Abstract: This application provides for methods of treatment for IBD, especially in subjects who have R. gnavus species or R. gnavus group IBD strains as a component of their microbiome. The application also provides for methods of diagnosing IBD, as well as kits for use in the claimed methods.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: November 7, 2023
    Assignees: The Broad Institute, Inc., The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Andrew Brantley Hall, Ramnik Xavier, Curtis Huttenhower, Moran Yassour, Hera Vlamakis
  • Cholesterol reducing compositions and methods of use thereof
    Patent number: 11633436
    Abstract: Microbes expressing cholesterol oxidoreductase (COR) proteins, methods of engineering the microbes expressing COR proteins, compositions and methods of using the microbes are provided.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: April 25, 2023
    Assignees: The Broad Institute, Inc., The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Douglas Kenny, Hera Vlamakis, Ramnik Xavier, Emily Balskus, Damian Plichta
  • CHOLESTEROL REDUCING COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20210128642
    Abstract: Microbes expressing cholesterol oxidoreductase (COR) proteins, methods of engineering the microbes expressing COR proteins, compositions and methods of using the microbes are provided.
    Type: Application
    Filed: September 18, 2020
    Publication date: May 6, 2021
    Inventors: Douglas KENNY, Hera VLAMAKIS, Ramnik XAVIER, Emily BALSKUS, Damian PLICHTA
  • METHODS OF TREATING AND DIAGNOSING IBD ASSOCIATED WITH R. GNAVUS AND/OR R. GNAVUS GROUP IBD COLONIZATION
    Publication number: 20200155617
    Abstract: This application provides for methods of treatment for IBD, especially in subjects who have R. gnavus species or R. gnavus group IBD strains as a component of their microbiome. The application also provides for methods of diagnosing IBD, as well as kits for use in the claimed methods.
    Type: Application
    Filed: April 20, 2018
    Publication date: May 21, 2020
    Applicants: The Broad Institute, Inc., The General Hospital Corporation, President and Fellows of Harvard College
    Inventors: Andrew Brantley Hall, Ramnik Xavier, Curtis Huttenhower, Moran Yassour, Hera Vlamakis